Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

Bernardi S, Voltan R, Rimondi E, Melloni E, Milani D, Cervellati C, Gemmati D, Celeghini C, Secchiero P, Zauli G, Tisato V.

Clin Sci (Lond). 2019 May 16;133(10):1145-1166. doi: 10.1042/CS20181116. Print 2019 May 31. Review.

2.

Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Parmeggiani F, Gallenga CE, Costagliola C, Semeraro F, Romano MR, Dell'Omo R, Russo A, De Nadai K, Gemmati D, D'Angelo S, Bolletta E, Sorrentino FS.

Sci Rep. 2019 Feb 22;9(1):2614. doi: 10.1038/s41598-019-38919-7.

3.

Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators.

Gemmati D, Occhionorelli S, Tisato V, Vigliano M, Longo G, Gonelli A, Sibilla MG, Serino ML, Zamboni P.

Sci Rep. 2018 Nov 16;8(1):16916. doi: 10.1038/s41598-018-35185-x.

4.

F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty.

Ansani L, Marchesini J, Pestelli G, Luisi GA, Scillitani G, Longo G, Milani D, Serino ML, Tisato V, Gemmati D.

Int J Mol Sci. 2018 Sep 14;19(9). pii: E2766. doi: 10.3390/ijms19092766.

5.

Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.

Tisato V, Zuliani G, Vigliano M, Longo G, Franchini E, Secchiero P, Zauli G, Paraboschi EM, Vikram Singh A, Serino ML, Ortolani B, Zurlo A, Bosi C, Greco A, Seripa D, Asselta R, Gemmati D.

PLoS One. 2018 Mar 8;13(3):e0193867. doi: 10.1371/journal.pone.0193867. eCollection 2018.

6.

Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review.

Sheykhansari S, Kozielski K, Bill J, Sitti M, Gemmati D, Zamboni P, Singh AV.

Cell Death Dis. 2018 Mar 1;9(3):348. doi: 10.1038/s41419-018-0379-2. Review.

7.

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories.

Perricone M, Palandri F, Ottaviani E, Angelini M, Bagli L, Bellesia E, Donati M, Gemmati D, Zucchini P, Mancini S, Marchica V, Trubini S, De Matteis G, Di Zacomo S, Favarato M, Fioroni A, Bolzonella C, Maccari G, Navaglia F, Gatti D, Toffolatti L, Orlandi L, Laloux V, Manfrini M, Galieni P, Giannini B, Tieghi A, Barulli S, Serino ML, Maccaferri M, Scortechini AR, Giuliani N, Vallisa D, Bonifacio M, Accorsi P, Salbe C, Fazio V, Gusella M, Toffoletti E, Salvucci M, Svaldi M, Gherlinzoni F, Cassavia F, Orsini F, Martinelli G.

Oncotarget. 2017 May 16;8(20):32608-32617. doi: 10.18632/oncotarget.15940.

8.

Quantitive evaluation of dentin sialoprotein (DSP) using microbeads - a potential early marker of root resorption.

Lombardo L, Carinci F, Martini M, Gemmati D, Nardone M, Siciliani G.

Oral Implantol (Rome). 2016 Nov 13;9(3):132-142. doi: 10.11138/orl/2016.9.3.132. eCollection 2016 Jul-Sep.

9.

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.

Gemmati D, Burini F, Talarico A, Fabbri M, Bertocco C, Vigliano M, Moratelli S, Cuneo A, Serino ML, Avato FM, Tisato V, Gaudio RM.

PLoS One. 2016 Sep 8;11(9):e0162084. doi: 10.1371/journal.pone.0162084. eCollection 2016.

10.

Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics.

Gemmati D, Vigliano M, Burini F, Mari R, El Mohsein HH, Parmeggiani F, Serino ML.

Curr Pharm Des. 2016;22(11):1449-59. Review.

PMID:
26654441
11.

Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.

Paraboschi EM, Cardamone G, Rimoldi V, Gemmati D, Spreafico M, Duga S, Soldà G, Asselta R.

Int J Mol Sci. 2015 Sep 30;16(10):23463-81. doi: 10.3390/ijms161023463.

12.

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Parmeggiani F, Costagliola C, Semeraro F, Romano MR, Rinaldi M, Gallenga CE, Serino ML, Incorvaia C, D'Angelo S, De Nadai K, Dell'Omo R, Russo A, Gemmati D, Perri P.

Int J Mol Sci. 2015 Aug 20;16(8):19796-811. doi: 10.3390/ijms160819796.

13.

The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X.

Branchini A, Baroni M, Burini F, Puzzo F, Nicolosi F, Mari R, Gemmati D, Bernardi F, Pinotti M.

J Thromb Haemost. 2015 Aug;13(8):1468-74. doi: 10.1111/jth.13034. Epub 2015 Jul 14.

14.

Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?

Gemmati D, Zeri G, Orioli E, Mari R, Moratelli S, Vigliano M, Marchesini J, Grossi ME, Pecoraro A, Cuneo A, Ferrari R, Pinotti M, Serino ML, Ansani L.

Thromb Haemost. 2015 Jul;114(1):123-32. doi: 10.1160/TH14-11-0952. Epub 2015 May 7.

PMID:
25947356
15.

Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study.

Castiglione A, Ciorba A, Aimoni C, Orioli E, Zeri G, Vigliano M, Gemmati D.

Biomed Res Int. 2015;2015:834736. doi: 10.1155/2015/834736. Epub 2015 Feb 18.

16.

Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.

Paraboschi EM, Rimoldi V, Soldà G, Tabaglio T, Dall'Osso C, Saba E, Vigliano M, Salviati A, Leone M, Benedetti MD, Fornasari D, Saarela J, De Jager PL, Patsopoulos NA, D'Alfonso S, Gemmati D, Duga S, Asselta R.

Hum Mol Genet. 2014 Dec 20;23(25):6746-61. doi: 10.1093/hmg/ddu392. Epub 2014 Jul 30.

PMID:
25080502
17.

Karyotype-phenotype correlation in partial trisomies of the short arm of chromosome 6: a family case report and review of the literature.

Castiglione A, Guaran V, Astolfi L, Orioli E, Zeri G, Gemmati D, Bovo R, Montaldi A, Alghisi A, Martini A.

Cytogenet Genome Res. 2013;141(4):243-59. doi: 10.1159/000353846. Epub 2013 Aug 7. Review.

18.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

19.

The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.

Hagleitner MM, Coenen MJ, Aplenc R, Patiño-Garcia A, Chiusolo P, Gemmati D, De Mattei M, Ongaro A, Krajinovic M, Hoogerbrugge PM, Vermeulen SH, te Loo DM.

Pharmacogenomics J. 2014 Apr;14(2):115-9. doi: 10.1038/tpj.2013.19. Epub 2013 May 7.

PMID:
23648444
20.

Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells.

Singh AV, Vyas V, Montani E, Cartelli D, Parazzoli D, Oldani A, Zeri G, Orioli E, Gemmati D, Zamboni P.

J Neurosci Rural Pract. 2012 Sep;3(3):301-10. doi: 10.4103/0976-3147.102611. Erratum in: J Neurosci Rural Pract. 2013 Jan-Mar;4(1):98. Maontani, Erica [corrected to Montani, Erica].

21.

Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.

Gemmati D, Zeri G, Orioli E, De Gaetano FE, Salvi F, Bartolomei I, D'Alfonso S, Dall'osso C, Leone MA, Singh AV, Asselta R, Zamboni P.

BMC Med Genet. 2012 Aug 10;13:70. doi: 10.1186/1471-2350-13-70.

22.

Genetic association and altered gene expression of mir-155 in multiple sclerosis patients.

Paraboschi EM, Soldà G, Gemmati D, Orioli E, Zeri G, Benedetti MD, Salviati A, Barizzone N, Leone M, Duga S, Asselta R.

Int J Mol Sci. 2011;12(12):8695-712. doi: 10.3390/ijms12128695. Epub 2011 Dec 1.

23.

Genetic predictors of response to photodynamictherapy.

Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, D'Angelo S, Romano MR, De Nadai K, Sebastiani A, Incorvaia C.

Mol Diagn Ther. 2011 Aug 1;15(4):195-210. doi: 10.2165/11592270-000000000-00000. Review.

PMID:
21913742
24.

Thrombophilia in the occurrence of retinal vascular infarction after photodynamic therapy with verteporfin using the standard protocol.

Parmeggiani F, Gemmati D, Costagliola C.

Arch Ophthalmol. 2010 Dec;128(12):1632; author reply 1632-3. doi: 10.1001/archophthalmol.2010.285. No abstract available.

PMID:
21149800
25.

Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer.

Singh AV, Subhashree L, Milani P, Gemmati D, Zamboni P.

Int J Low Extrem Wounds. 2010 Dec;9(4):166-79. doi: 10.1177/1534734610384653. Epub 2010 Nov 30. Review.

PMID:
21118859
26.

Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.

Parmeggiani F, Costagliola C, Incorvaia C, Sebastiani A, Gemmati D.

Curr Drug Targets. 2011 Feb;12(2):138-48. Review.

PMID:
20887247
27.

Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Ferlini A, Bovolenta M, Neri M, Gualandi F, Balboni A, Yuryev A, Salvi F, Gemmati D, Liboni A, Zamboni P.

BMC Med Genet. 2010 Apr 28;11:64. doi: 10.1186/1471-2350-11-64.

28.

Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.

Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, D'Angelo S, Perri P, Sebastiani A, Incorvaia C.

Ophthalmology. 2010 Mar;117(3):517-23. doi: 10.1016/j.ophtha.2009.08.028. Epub 2009 Dec 30.

PMID:
20044141
29.

DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators.

Gemmati D, Federici F, Catozzi L, Gianesini S, Tacconi G, Scapoli GL, Zamboni P.

J Vasc Surg. 2009 Dec;50(6):1444-51. doi: 10.1016/j.jvs.2009.07.103.

30.

Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.

Ongaro A, De Mattei M, Della Porta MG, Rigolin G, Ambrosio C, Di Raimondo F, Pellati A, Masieri FF, Caruso A, Catozzi L, Gemmati D.

Haematologica. 2009 Oct;94(10):1391-8. doi: 10.3324/haematol.2009.008326. Epub 2009 Jul 31.

31.

DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing?

Gemmati D, De Mattei M, Catozzi L, Della Porta M, Serino ML, Ambrosio C, Cuneo A, Friso S, Krampera M, Orioli E, Zeri G, Ongaro A.

Am J Hematol. 2009 Aug;84(8):526-9. doi: 10.1002/ajh.21451. No abstract available.

32.

Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Parmeggiani F, Gemmati D, Costagliola C, Sebastiani A, Incorvaia C.

Recent Pat DNA Gene Seq. 2009;3(2):114-22. Review.

PMID:
19519581
33.

Multiple strokes in a newborn.

Semeraro F, Bertazzi L, Gasparotti R, Costagliola C, Gemmati D, Catozzi L, Parmeggiani F.

Ophthalmology. 2009 Apr;116(4):812-3, 813.e1-3. doi: 10.1016/j.ophtha.2008.12.012. No abstract available.

PMID:
19344828
34.

Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction.

Ferraresi P, Campo G, Marchetti G, Pinotti M, Valgimigli M, Gemmati D, Ferrari R, Bernardi F.

Clin Appl Thromb Hemost. 2009 Feb;15(1):119-22. doi: 10.1177/1076029607308875. No abstract available.

PMID:
19150996
35.

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Parmeggiani F, Gemmati D, Costagliola C, Sebastiani A, Incorvaia C.

Pharmacogenomics. 2009 Jan;10(1):81-95. doi: 10.2217/14622416.10.1.81. Review.

PMID:
19102718
36.

Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration.

Parmeggiani F, Costagliola C, Gemmati D, D'Angelo S, Perri P, Campa C, Catozzi L, Federici F, Sebastiani A, Incorvaia C.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3100-6. doi: 10.1167/iovs.07-1654. Epub 2008 Mar 31.

PMID:
18378576
37.

Time- and dose-dependent effects of chronic wound fluid on human adult dermal fibroblasts.

De Mattei M, Ongaro A, Magaldi S, Gemmati D, Legnaro A, Palazzo A, Masieri F, Pellati A, Catozzi L, Caruso A, Zamboni P.

Dermatol Surg. 2008 Mar;34(3):347-56. doi: 10.1111/j.1524-4725.2007.34068.x. Epub 2007 Dec 20.

PMID:
18177397
38.

Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.

Parmeggiani F, Costagliola C, Gemmati D, D'Angelo S, Perri P, Scapoli GL, Catozzi L, Federici F, Sebastiani A, Incorvaia C.

Pharmacogenet Genomics. 2007 Dec;17(12):1039-46.

PMID:
18004208
39.

Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.

Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, Federici F, Ferrari F, Tebaldi M, Luccarelli S, Parrinello G, Ferrari R.

J Am Coll Cardiol. 2007 Sep 18;50(12):1132-7. Epub 2007 Sep 4.

40.
41.

Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.

Gemmati D, Federici F, Campo G, Tognazzo S, Serino ML, De Mattei M, Valgimigli M, Malagutti P, Guardigli G, Ferraresi P, Bernardi F, Ferrari R, Scapoli GL, Catozzi L.

Mol Med. 2007 Jan-Feb;13(1-2):112-20.

42.

Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.

Gemmati D, Ongaro A, Tognazzo S, Catozzi L, Federici F, Mauro E, Della Porta M, Campioni D, Bardi A, Gilli G, Pellati A, Caruso A, Scapoli GL, De Mattei M.

Haematologica. 2007 Apr;92(4):478-85.

43.

Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, Catozzi L, Malagutti P, Anselmi M, Vassanelli C, Scapoli G, Ferrari R.

J Am Coll Cardiol. 2006 Dec 5;48(11):2178-85. Epub 2006 Nov 13.

44.

Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.

Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, Bernardi F.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2800-6. Epub 2006 Sep 28.

PMID:
17008590
45.

Influence of gene polymorphisms in ulcer healing process after superficial venous surgery.

Gemmati D, Tognazzo S, Catozzi L, Federici F, De Palma M, Gianesini S, Scapoli GL, De Mattei M, Liboni A, Zamboni P.

J Vasc Surg. 2006 Sep;44(3):554-62.

46.

Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers.

Tognazzo S, Gemmati D, Palazzo A, Catozzi L, Carandina S, Legnaro A, Tacconi G, Scapoli GL, Zamboni P.

J Vasc Surg. 2006 Oct;44(4):815-9. Epub 2006 Aug 30.

47.

Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields.

De Mattei M, Fini M, Setti S, Ongaro A, Gemmati D, Stabellini G, Pellati A, Caruso A.

Osteoarthritis Cartilage. 2007 Feb;15(2):163-8. Epub 2006 Aug 14.

48.

The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis.

Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, Caggiati A, Scapoli G, Gemmati D.

Free Radic Biol Med. 2006 May 15;40(10):1869-73. Epub 2006 Feb 14.

PMID:
16678024
49.

Vision loss after PDT.

Parmeggiani F, Costagliola C, Incorvaia C, Campa C, Gemmati D, Tognazzo S, Sebastiani A.

Ophthalmology. 2006 Jan;113(1):157. No abstract available.

PMID:
16389108
50.

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.

Klein CL, Márki-Zay J, Corbisier P, Gancberg D, Cooper S, Gemmati D, Halbmayer WM, Kitchen S, Melegh B, Neumaier M, Oldenburg J, Leibundgut EO, Reitsma PH, Rieger S, Schimmel HG, Spannagl M, Tordai A, Tosetto A, Visvikis S, Zadro R, Mannhalter C.

Clin Chem Lab Med. 2005;43(8):862-8.

PMID:
16201898

Supplemental Content

Loading ...
Support Center